Repigmentation in facial vitiligo depends on the affected areas

It is currently not well documented whether the chance of repigmentation differs by location on the face. We conducted a retrospective analysis of 36 vitiligo patients treated with topical treatment and methotrexate with facial vitiligo with or without additional phototherapy. While vitiligo on the forehead and temporal sides of the face was a good prognostic factor, the broad areas around the eyes and mouth represent more treatment-resistant parts.